Videos
The Unmet Need in Severe Aortic Regurgitation: Are We Ready for TAVI?
The prevalence of valvular heart disease increases with advanced age and, unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022 Tanja Rudolph raises the question: Are we ready for TAVR in aortic regurgitation?
Latest News
View All
Press
April 1, 2026
JenaValve Announces Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the US
Read More
Press
March 18, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More